MacroGenics Net Income Per Share from 2010 to 2024

MGNX Stock  USD 3.29  0.05  1.54%   
MacroGenics Net Loss yearly trend continues to be fairly stable with very little volatility. Net Loss will likely drop to -0.15 in 2024. During the period from 2010 to 2024, MacroGenics Net Loss regression line of annual values had r-squared of  0.20 and arithmetic mean of (1.21). View All Fundamentals
 
Net Loss  
First Reported
2010-12-31
Previous Quarter
(0.15)
Current Value
(0.15)
Quarterly Volatility
1.47946413
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check MacroGenics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MacroGenics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 7.3 M, Interest Expense of 1.5 M or Selling General Administrative of 37 M, as well as many indicators such as Price To Sales Ratio of 9.98, Dividend Yield of 0.0 or PTB Ratio of 4.1. MacroGenics financial statements analysis is a perfect complement when working with MacroGenics Valuation or Volatility modules.
  
Check out the analysis of MacroGenics Correlation against competitors.
For more information on how to buy MacroGenics Stock please use our How to Invest in MacroGenics guide.

Latest MacroGenics' Net Income Per Share Growth Pattern

Below is the plot of the Net Income Per Share of MacroGenics over the last few years. It is MacroGenics' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in MacroGenics' overall financial position and show how it may be relating to other accounts over time.
Net Income Per Share10 Years Trend
Slightly volatile
   Net Income Per Share   
       Timeline  

MacroGenics Net Income Per Share Regression Statistics

Arithmetic Mean(1.21)
Geometric Mean0.73
Coefficient Of Variation(122.40)
Mean Deviation1.25
Median(0.63)
Standard Deviation1.48
Sample Variance2.19
Range4.6504
R-Value(0.45)
Mean Square Error1.88
R-Squared0.20
Significance0.09
Slope(0.15)
Total Sum of Squares30.64

MacroGenics Net Income Per Share History

2023 -0.15
2022 -1.95
2021 -3.18
2020 -2.25
2019 -3.16
2018 -4.19
2017 -0.54

About MacroGenics Financial Statements

MacroGenics investors use historical fundamental indicators, such as MacroGenics' Net Income Per Share, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in MacroGenics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Loss(0.15)(0.15)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for MacroGenics Stock Analysis

When running MacroGenics' price analysis, check to measure MacroGenics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MacroGenics is operating at the current time. Most of MacroGenics' value examination focuses on studying past and present price action to predict the probability of MacroGenics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MacroGenics' price. Additionally, you may evaluate how the addition of MacroGenics to your portfolios can decrease your overall portfolio volatility.